MACMANUS GROUP, INC., THE – Trademark Portfolio

Entity Type: 03

MACMANUS GROUP, INC., THE holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 7 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MEDIAVEST. The owner is based in NEW YORK, NY.

1675 BROADWAY

NEW YORK, NY 10019

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MACMANUS GROUP, INC., THE's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (7 filings)

Advertising; business management; business administration; office functions

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Frequently Asked Questions

How many trademarks does MACMANUS GROUP, INC., THE have?

MACMANUS GROUP, INC., THE has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 4 cancelled.

What trademark classes does MACMANUS GROUP, INC., THE file in?

MACMANUS GROUP, INC., THE files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 16 (Paper Goods). Class 35 covers advertising; business management; business administration; office functions.

What are MACMANUS GROUP, INC., THE's most well-known trademarks?

MACMANUS GROUP, INC., THE's registered trademark portfolio includes well-known marks such as MEDIAVEST. These are among 1 currently registered trademark in the portfolio.

What is MACMANUS GROUP, INC., THE's trademark registration success rate?

MACMANUS GROUP, INC., THE has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.